Power Law company profile

Quell Therapeutics

Biotech & Life Sciences · London, United Kingdom · Founded 2019 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Investors

17 investors on Quell Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Syncona

UCL Technology Fund

AlbionVC

Series B+ 14 investors entered at this stage

Future Fund

Breakthrough Energy Ventures

Ridgeback Capital

King's College London

Tekla Capital Management

Medizinische Hochschule Hannover

University College London

SV Health Investors

British Patient Capital

Monashee Investment Management

Jeito Capital

Fidelity Investments

Janus Henderson Investors

Point72 Ventures

Global footprint

Where Quell Therapeutics has talent and traffic

Web traffic by country

9.7K monthly visits
across markets

🇬🇧 United Kingdom58.8%

🇺🇸 United States29.9%

🇮🇳 India10.3%

🇯🇵 Japan2.1%

Top 4 markets shown

See Quell Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo